Pacific Biosciences Of California | PACB - Cost Of Sales

Stock Price
1.72
Daily Change
0.03 1.78%
Monthly
23.74%
Yearly
50.88%
Q2 Forecast
1.65

Pacific Biosciences Of California reported $28.9M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Bruker USD 528M 46.9M Dec/2025
Danaher USD 2.87B 342M Dec/2025
General Electric Aerospace USD 8.92B 654M Dec/2025
Illumina USD 400M 49M Dec/2025
Myriad Genetics USD 63M 1.1M Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Standard Biotools USD 12.41M 2.34M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Waters USD 374.94M 47.13M Dec/2025